Meningococcal Vaccines Market Size, Share, Analysis, Trends, Growth, Forecasts 2032

Meningococcal Vaccines Market Industry Prospective

The global Meningococcal Vaccines Market size was valued at USD 3.77 Billion in 2023 and is predicted to reach USD 6.32 Billion by the end of 2032. The market is expected to grow with a CAGR of 5.9% during the forecast period. The report analyzes the global Meningococcal Vaccines Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Meningococcal Vaccines industry.

Request Free Sample

Meningococcal Vaccines Market: Overview

Meningococcal vaccine treats meningitidis that is caused by bacteria N. These vaccines are administered via injections. In nations with low illness danger, they suggest immunizing high-risk groups. Generally, meningococcal vaccines are secure, but some individuals may feel pain and redness at the injection site. However, in less than one in a million doses, severe allergic responses are recorded.

Meningococcal Vaccines Market: Growth Dynamics

Developing nations like Brazil, Russia, India, China, and South Africa are progressively engaged in improvising and expanding their health infrastructure along with investing heavily in innovation in health, progressively impacting the health procedures worldwide. Thus, to develop innovative health technologies, the Indian government is increasingly investing in the early phase of different research and development projects. Therefore, high-quality, low-cost vaccines produced by developing countries are likely to drive the meningococcal vaccines market. Furthermore, rising awareness about the meningococcal vaccines is also fuelling the meningococcal vaccines market development. Many leading companies are collaborating with non-profit organizations to create awareness about the disease and its various treatment options for meningococcal infections. Visits to healthcare facilities should be used to evaluate the status of immunization and administer suggested vaccines to allow maximum number of adolescents access to these vaccines. Alternative sites can also be used to maximize vaccination possibilities, such as colleges or pharmacies.

The report covers a forecast and an analysis of the meningococcal vaccines market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the meningococcal vaccine market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the meningococcal vaccines market on a global level.

Request Free Sample

In order to give the users of this report a comprehensive view of the meningococcal Vaccines Market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, where all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides a company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launches, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolios of various companies according to regions.

Meningococcal Vaccines Market Segmentation Analysis

The study provides a decisive view of the meningococcal vaccine market by segmenting it based on type, end-user, and region.

The meningococcal vaccines market is fragmented into type and end-user. Based on type, the market is classified into combination (MenHibrix and Menitorix), polysaccharide (NmVac4, Mencevax, Menomune, and others), conjugate (Menjugate, Nimenrix, Menveo, Menactra, NeisVac-C, MenAfriVac, Meningitec, and NmVac4-DT), and Men B vaccines (Bexsero and Trumenba). The end-user segment is classified into hospital pharmacies, retail pharmacies, and others.

Regional Analysis

North America is anticipated to lead the meningococcal vaccines market worldwide, owing to the increasing public measures and prevention programs and research and growth projects by multiple regional producers. Group-B vaccines have been custom-made for particular epidemic strains and are widely used in Cuba, Brazil, New Zealand, France, Chile, and Norway. In developed nations like Australia, Canada, and certain European countries, the incidence of meningococcal illnesses decreased before the advent of the vaccine, which further accelerated the disease's decline. This is followed by the regions of Latin America and the Middle East and Africa. Due to low production costs and increased healthcare expenditure, the Asia Pacific region is anticipated to be the fastest-growing in the meningococcal vaccines market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa.

Meningococcal Vaccines Market: Report Scope

Some key players in the meningococcal vaccines market are:

• Novartis International
• Nuron Biotech
• GlaxoSmithKline
• Pfizer
• Sanofi
• JN-International Medical
• Baxter International
• Serum Institute of India
• Biomed.

This report segments the global meningococcal vaccines market into:

Global Meningococcal Vaccines Market: Type Analysis

• Combination Vaccines

  • Menhibrix
  • Menitorix
• Polysaccharide Vaccines
  • Nmvac4
  • Menomune
  • Mencevax
  • Others
• Conjugate Vaccines
  • Nimenrix
  • Menactra
  • Menveo
  • Menafrivac
  • Neisvac-C
  • Meningitec
  • Menjugate
  • Nmvac4-Dt
• Men B Vaccines
  • Bexsero
  • Trumenba

Global Meningococcal Vaccines Market: End-User Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Meningococcal Vaccines Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa